The company
KORU Medical Systems, Inc.
KRMD · Nasdaq
KRMD stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 20.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 33
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $431K
- Insider sales, 12 months
- $0
- Insider trades held for review
- 2, left out of the totals
- Officials’ trades on record
- 0
- Institutions holding
- 83 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. 2 trades held for review are left out until their prices have been checked.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Adam R. KalbermattenChief Commercial Officer | bought | 32,000at $3.16 | 8 Sep 2026filed 9 Sep 2026 |
| Adam R. KalbermattenPresident-Chief Commercial Off | bought | 5,000at $3.96 | 11 Jun 2026filed 15 Jun 2026 |
| Adam R. KalbermattenPresident-Chief Commercial Off | bought | 7,500at $3.93 | 11 Jun 2026filed 15 Jun 2026 |
| Eric SchillerChief Technology Officer | bought | 5,000at $3.91 | 18 May 2026filed 20 May 2026 |
| Linda M. TharbyChief Executive Officer | bought | 1,191price held for review | 15 May 2026filed 20 May 2026 |
| Linda M. TharbyChief Executive Officer | bought | 1,191at $3.92 | 15 May 2026filed 20 May 2026 |
| Thomas Edward AdamsChief Financial Officer | bought | 5,041at $3.86 | 14 May 2026filed 18 May 2026 |
| Thomas Edward AdamsChief Financial Officer | bought | 459at $3.90 | 14 May 2026filed 18 May 2026 |
| Christopher PazdanChief Operating Officer | bought | 5,000at $3.88 | 14 May 2026filed 18 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| First Light Asset Management, LLCreduced · filed 14 Aug 2026 | 3,387,902$14.2M | -380,478−10.1% |
| Topline Capital Management, LLCreduced · filed 14 Aug 2026 | 3,373,842$14.2M | -141,069−4.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,628,352$11.0M | +256,526+10.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,818,121$7.6M | +131,897+7.8% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,128,096$4.7M | +76,888+7.3% |
| Simcoe Capital LLCadded · filed 6 Aug 2026 | 827,393$3.5M | +16,146+2.0% |
| Meros Investment Management, LPreduced · filed 14 Aug 2026 | 759,664$3.2M | -787−0.1% |
| Lionhunter Capital Management, LLCnew · filed 13 Aug 2026 | 693,139$2.9M | +693,139 |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 646,572$2.7M | -2,657−0.4% |
| Archon Capital Management LLCunchanged · filed 14 Aug 2026 | 642,923$2.7M | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.